Table of Contents
Cephalosporins are a widely used class of β-lactam antibiotics that play a crucial role in treating bacterial infections. Understanding their pharmacokinetics is essential for optimizing therapeutic efficacy and minimizing resistance. This article explores the absorption, distribution, metabolism, and excretion of cephalosporins.
Absorption of Cephalosporins
Cephalosporins are generally well absorbed after oral administration, although the extent varies among different generations. First-generation cephalosporins, such as cephalexin, exhibit good oral bioavailability, typically ranging from 70% to 90%. Higher-generation cephalosporins, like ceftriaxone, are often administered parenterally due to poor oral absorption.
Factors influencing absorption include gastrointestinal pH, presence of food, and formulation. For example, food may delay absorption but usually does not significantly reduce the overall bioavailability of many oral cephalosporins.
Distribution of Cephalosporins
Cephalosporins are widely distributed throughout body tissues and fluids. They penetrate well into the cerebrospinal fluid (CSF), especially in the presence of meningeal inflammation, making them effective against central nervous system infections.
Protein binding varies among cephalosporins, influencing their free (active) concentrations. For instance, ceftriaxone exhibits high protein binding (~85-95%), while cefazolin has moderate binding (~80%). This affects their distribution volume and duration of action.
Metabolism of Cephalosporins
Most cephalosporins undergo minimal hepatic metabolism. They are primarily excreted unchanged in urine. However, some, like ceftriaxone, may undergo partial hepatic conjugation, facilitating biliary excretion.
The stability of the β-lactam ring in cephalosporins makes them susceptible to β-lactamase enzymes, which can inactivate the drug. Resistance mechanisms include enzymatic degradation and alterations in penicillin-binding proteins (PBPs).
Excretion of Cephalosporins
Renal excretion is the primary route for most cephalosporins, occurring via glomerular filtration and active tubular secretion. The half-life of these drugs is influenced by renal function, necessitating dose adjustments in renal impairment.
Ceftriaxone is an exception, with significant biliary excretion, allowing for less frequent dosing and use in patients with renal impairment. Monitoring renal function is essential to avoid accumulation and toxicity.
Clinical Implications
Understanding the pharmacokinetics of cephalosporins guides appropriate dosing, especially in special populations such as those with renal or hepatic impairment. It also informs choices between oral and parenteral administration based on infection site and severity.
Therapeutic drug monitoring may be necessary for certain cephalosporins to optimize efficacy and minimize adverse effects. Adjustments in dosing regimens help prevent resistance development and ensure effective bacterial eradication.